FDA clears more saline imports to address shortage


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON (AP) — Federal health regulators are allowing a U.S. medical supply company to import saline solution from its Spanish plant to address a national shortage of the hospital staple.

The Food and Drug Administration announcement is the latest effort to increase U.S. supplies of the salt solution, which is used to rehydrate hospital patients and assist in the delivery of drugs.

The agency said late Monday that it cleared Baxter Healthcare to import saline solution from its facility in Spain after FDA inspectors verified that it meets U.S. standards. Last month the FDA cleared another company, Fresenius Kabi, to import saline from its Norway plant.

The FDA began receiving reports of a supply problem from hospitals in December due to production delays, maintenance problems and other issues.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast